AIM ImmunoTech Future Growth

Future criteria checks 2/6

AIM ImmunoTech is forecast to grow earnings and revenue by 6.5% and 66.1% per annum respectively while EPS is expected to grow by 11% per annum.

Key information

6.5%

Earnings growth rate

11.0%

EPS growth rate

Biotechs earnings growth37.8%
Revenue growth rate66.1%
Future return on equityn/a
Analyst coverage

Low

Last updated21 Oct 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

LSE:0A4Y - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20264-16N/AN/A2
12/31/20252-16N/A-63
12/31/20240-18N/A-83
6/30/20240-28-24-23N/A
3/31/20240-31-23-22N/A
12/31/20230-29-22-21N/A
9/30/20230-21-18-18N/A
6/30/20230-19-17-17N/A
3/31/20230-19-17-17N/A
12/31/20220-19-16-16N/A
9/30/20220-21-16-16N/A
6/30/20220-18-15-14N/A
3/31/20220-19-14-14N/A
12/31/20210-19-15-14N/A
9/30/20210-17-12-11N/A
6/30/20210-17-11-11N/A
3/31/20210-14-11-10N/A
12/31/20200-14-11-10N/A
9/30/20200-12-10-10N/A
6/30/20200-11-10-9N/A
3/31/20200-10-11-11N/A
12/31/20190-9-9-9N/A
9/30/20190-10-9-9N/A
6/30/20190-10-10-10N/A
3/31/20190-10-10-10N/A
12/31/20180-10-11-11N/A
9/30/20180-10-9-9N/A
6/30/20180-8-8-8N/A
3/31/20180-8N/A-7N/A
12/31/20170-8N/A-8N/A
9/30/20170-7N/A-9N/A
6/30/20170-9N/A-10N/A
3/31/20170-8N/A-9N/A
12/31/20160-8N/A-7N/A
9/30/20160-9N/A-9N/A
6/30/20160-10N/A-9N/A
3/31/20160-14N/A-13N/A
12/31/20150-15N/A-16N/A
9/30/20150-17N/A-17N/A
6/30/20150-17N/A-17N/A
3/31/20150-17N/A-15N/A
12/31/20140-17N/A-14N/A
9/30/20140-16N/A-13N/A
6/30/20140-17N/A-13N/A
3/31/20140-16N/A-14N/A
12/31/20130-16N/A-17N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 0A4Y is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: 0A4Y is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: 0A4Y is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: 0A4Y's revenue (66.1% per year) is forecast to grow faster than the UK market (3.6% per year).

High Growth Revenue: 0A4Y's revenue (66.1% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 0A4Y's Return on Equity is forecast to be high in 3 years time


Discover growth companies